Drugdiscovery >> Pharmaceutical Companies >> News
2128
Views
title
Novartis has announced the results of phase 4 INSTEAD study - drugdiscovery.com


Novartis has announced the result of a Phase 4 INSTEAD research made to imporve its new COPD drug. Once-daily indacaterol has shown very promising data.
Read More >>


Tags: durg development, INSTEAD Swift study, GSK, Novartis, pharmaceutical news, pharmaceutical companies - April 29, 2014
Related Articles
1430
Views
Neumedicines ha a new Phase I study Neumedicines ha a new Phase I study
Neumedicines announced that their proposal to conduct a Phase I clinical study of recombinant human interleukin-12 (rHuIL-12) for the treatment of traumatic wounds has been recommended for funding sub Read More >>

Tags: Neumedicines, phase I study, phase I clinical trial, drugresearch, drug discovery

1233
Views
Novartis experiences a solid growth Novartis experiences a solid growth
Perhaps as the result of definitive agreements with GSK and Eli Lilly, Novartis announced that it has produced a solid growth in the subsequent quarter's end. Read More >>

Tags: Novartis, sotck growth, pharmaceutical growth, novartis stocks

1034
Views
Dramatic job-cuts at Novartis Dramatic job-cuts at Novartis
Novartis announced 500 Swiss job cuts. The company started to outsource a large part of its services to India. Read More >>

Tags: novartis, india,jobcut, outsourcing

4019
Views
Novartis has named the new leaders of Alcon and Sandoz Novartis has named the new leaders of Alcon and Sandoz
These new leaders will set the direction for the next phase of growth for our eye care and generics businesses, two of our core growth engines. Read More >>

Tags: biosimilars, pharmaceutical business, pharma leaders, novartis, alcon, sandoz, drug, drug ceo, Chutes and Ladders, Novartis, Sandoz,

2143
Views
Novartis contributes with GSK and changes protfolio Novartis contributes with GSK and changes protfolio
Novartis announced that it is going to transform its portfolio and strenghtens its researches by acquiring products of GSK's oncology wing. Read More >>

Tags: GSK, Novartis, pharmaceutical companies, pharmaceutical news, drug discovery, oncology srugs

5306
Views
Isis shares climbe after positive results from its spinal muscular atrophy drug study Isis shares climbe after positive results from its spinal muscular atrophy drug study
Isis Pharmaceuticals drug designed to treat spinal muscular atrophy showed success in a mid- stage study. This announcement led to a raise of company’s shares. Read More >>

Tags: news, Isis Pharmaceutical, spinal muscular atrophy, clinical trial, shares, experimental drug

1968
Views
A partership between Novartis and Ensemble Therapeutics A partership between Novartis and Ensemble Therapeutics
The two companies have signed the agreement to join their forces in development of experimental therapeutic candidates for the treatment of autoimmune diseases. Read More >>

Tags: Novartis, Ensemble Therapeutics, pact, partnership, inflammation, IL-17, autoimmune diseases

3786
Views
GlaxoSmithKline and Novartis sigent a three-part agreemnet GlaxoSmithKline and Novartis sigent a three-part agreemnet
GSK will accquire vaccines of Novartis. This is only one point of the three-part agreement which was signed by the two pharmaceutical giants. Both companies hope development. Read More >>

Tags: novartis, GKS, vaccination business, pharmaceutical business, pharmaceutical news, pharmaceutical business news.

1158
Views
Novozymes announced that its Novozymes announced that its "Veltis' is going t be used by GSK
Novonenzymes announced that GSK can use its "Veltis", a half-life extension technology for Eperzan, the recently accepted drug of the company. Read More >>

Tags: Veltis, GKS, Novozymes, extension, drug discovery, Eperzan, diabetes, type 2 diabetes

4047
Views
A new leukemia drug id going to be made by Pfizer A new leukemia drug id going to be made by Pfizer
Avalliaon Group and Pfizer work together on developing a new type of pharma. The leukemia drug is in Phase 3 clinical trial now. Read More >>

Tags: Phase , clinical trial, pharma

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013